Effect of trazodone on hERG channel current and QT-interval
Tài liệu tham khảo
ADIS International, 1998
Ankier, 1981, Trazodone—a new assay procedure and some pharmacokinetic parameters, Br. J. Clin. Pharmacol., 11, 505, 10.1111/j.1365-2125.1981.tb01157.x
Brown, 2000, Drug-induced long QT syndrome: is HERG the root of all evil?, Pharm. News, 7, 15
Burgess, 1982, The electrocardiographic and anticholinergic effects of trazodone and imipramine in man, Eur. J. Clin. Pharmacol., 23, 417, 10.1007/BF00605991
Byrne, 1982, Differential effects of trazodone and imipramine on intracardiac conduction in the anesthetized dog, Arch. Int. Pharmacodyn. Ther., 259, 259
Chiang, 2004, Inhibition of L-type Ca(2+) current in guinea pig ventricular myocytes by cisapride, J. Biomed. Sci., 11, 303
Crumb, 2000, Loratadine blockade of K(+) channels in human heart: comparison with terfenadine under physiological conditions, J. Pharmacol. Exp. Ther., 292, 261
de Meester, 2001, Fatal overdose with trazodone: case report and literature review, Acta Clin. Belg., 56, 258, 10.1179/acb.2001.038
De Ponti, 2002, Safety of nonantiarrhythmic drugs that prolong the QT-interval or induce torsades de pointes: an overview, Drug Saf., 25, 263, 10.2165/00002018-200225040-00004
Ducic, 1997, Comparative effects of loratadine and terfenadine on cardiac K+ channels, J. Cardiovasc. Pharmacol., 30, 42, 10.1097/00005344-199707000-00007
Gintant, 2001, The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis, J. Cardiovasc. Pharmacol., 37, 607, 10.1097/00005344-200105000-00012
Goodman, 2001
Hayes, 1986, Adverse reactions to five new antidepressants, Clin. Pharm., 5, 471
Janowsky, 1983, Trazodone-aggravated ventricular arrhythmias, J. Clin. Psychopharmacol., 3, 372, 10.1097/00004714-198312000-00010
Lefebvre, 1997, Influence of itraconazole on the pharmacokinetics and electrocardiographic effects of astemizole, Br. J. Clin. Pharmacol., 43, 319, 10.1046/j.1365-2125.1997.00548.x
Levenson, 1999, Prolonged QT-interval after trazodone overdose, Am. J. Psychiatry, 156, 969, 10.1176/ajp.156.6.969a
Mazur, 1995, QT prolongation and polymorphous ventricular tachycardia associated with trasodone–amiodarone combination, Int. J. Cardiol., 52, 27, 10.1016/0167-5273(95)02435-Y
Mohammad, 1997, Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride, Am. J. Physiol., 273, H2534
Park, 1999, Fluoxetine inhibits L-type Ca2+ and transient outward K+ currents in rat ventricular myocytes, Yonsei Med. J., 40, 144, 10.3349/ymj.1999.40.2.144
Physicians' Desk Reference, 1997. Thomson Healthcare, Montvale, NJ.
Physicians' Desk Reference, 1998. Thomson Healthcare, Montvale, NJ.
Pohl, 1986, Effects of trazodone and desipramine on cardiac rate and rhythm in a patient with preexisting cardiovascular disease, J. Clin. Psychopharmacol., 6, 380, 10.1097/00004714-198612000-00022
Rampe, 1997, A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG, FEBS Lett., 417, 28, 10.1016/S0014-5793(97)01249-0
Redfern, 2003, Relationships between preclinical cardiac electrophysiology, clinical QT-interval prolongation and torsades de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development, Cardiovasc. Res., 58, 32, 10.1016/S0008-6363(02)00846-5
Roden, 2004, Drug-induced prolongation of the QT-interval, N. Engl. J. Med., 350, 1013, 10.1056/NEJMra032426
Roy, 1996, HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine, Circulation, 94, 817, 10.1161/01.CIR.94.4.817
Tibbles, 1997, Trazodone cardiotoxicity following overdose, J. Toxicol., Clin. Toxicol., 35, 499
Van de Merwe, 1984, Electrophysiological and haemodynamic changes with trazodone, amitriptyline and placebo in depressed outpatients, Curr. Med. Res. Opin., 9, 339, 10.1185/03007998409109602
Vitullo, 1990, Trazodone-related exercise-induced nonsustained ventricular tachycardia, Chest, 98, 247, 10.1378/chest.98.1.247
Webster, 2001, Pharmacokinetic/pharmacodynamic assessment of the effects of E4031, cisapride, terfenadine and terodiline on monophasic action potential duration in dog, Xenobiotica, 31, 633, 10.1080/00498250110054632
Wittebole, 2000, Trazodone poisoning with torsades de pointes and prolonged need for inotropic support, J. Toxicol., Clin. Toxicol., 38, 248
Zhou, 1999, Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole, J. Cardiovasc. Electrophysiol., 10, 836, 10.1111/j.1540-8167.1999.tb00264.x
Zitron, 2004, Inhibition of cardiac HERG potassium channels by the atypical antidepressant trazodone, Naunyn-Schmiedeberg's Arch. Pharmacol., 370, 146, 10.1007/s00210-004-0952-3